Funded Project Details - FY2021
|Title:|| Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction|
|Congressional District Code:
||Clinical Science R&D
|| July 2018 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Type 2 diabetes (T2D) and cardiovascular disease (CVD) are among the leading causes of morbidity and mortality in US Veterans, as well as the US population at large. T2D is a widely-recognized risk factor for CVD, and T2D leads to worse CVD outcomes. However, there remains considerable clinical heterogeneity among individuals with T2D. Even among individuals with apparently similar glycemic control, there is significant variability with respect to who will develop CVD. To develop more effective...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.